ALXO insider trading — ALX Oncology Holdings Inc
Over the last 90 days, insiders at ALX Oncology Holdings Inc (ALXO) made 0 open-market purchases worth $0 and 2 open-market sales worth $5K, making them net sellers by $5K. The largest sale was by Lettmann Jason (CHIEF EXECUTIVE OFFICER), who sold 2,230 shares for $4K on Aug 17, 2026.
Updated Oct 16, 2026.
Recent ALXO insider transactions
Every Form 4 filed by ALX Oncology Holdings Inc officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Lettmann Jason | CHIEF EXECUTIVE OFFICER | S · Sale | Direct | 2,230 | $1.93 | $4K | Form 4 |
| Aug 17, 2026 | Wong Shelly | SVP, FINANCE AND CAO | S · Sale | Direct | 573 | $1.93 | $1K | Form 4 |
ALXO insider trading FAQ
Are insiders buying ALXO stock?
Not on the open market. In the last 90 days, ALX Oncology Holdings Inc insiders made no open-market purchases, and 2 open-market sales totaling $5K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading ALXO?
Recent sellers: Lettmann Jason, Wong Shelly.
Where does ALXO insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.